Michael S. Milder

519 total citations
12 papers, 417 citations indexed

About

Michael S. Milder is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, Michael S. Milder has authored 12 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in Michael S. Milder's work include CAR-T cell therapy research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Michael S. Milder is often cited by papers focused on CAR-T cell therapy research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Michael S. Milder collaborates with scholars based in United States. Michael S. Milder's co-authors include Gerald S. Johnston, James D. Cook, Clement A. Finch, Sunday M. Stray, Steven M. Larson, George P. Canellos, James C. Arseneau, Gregory B. Bulkley, R. Frankel and Alfred S. Ketcham and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Michael S. Milder

12 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Milder United States 7 144 94 84 79 77 12 417
P H Schur United States 9 91 0.6× 156 1.7× 41 0.5× 59 0.7× 30 0.4× 12 490
Le Goff P France 11 72 0.5× 47 0.5× 10 0.1× 72 0.9× 44 0.6× 63 420
J A Penner United States 8 547 3.8× 156 1.7× 16 0.2× 53 0.7× 41 0.5× 16 665
Hagit Miskin Israel 12 195 1.4× 190 2.0× 26 0.3× 18 0.2× 45 0.6× 24 455
P. Reekers Netherlands 12 165 1.1× 24 0.3× 27 0.3× 229 2.9× 21 0.3× 30 720
J Yvart France 11 192 1.3× 87 0.9× 13 0.2× 13 0.2× 65 0.8× 33 403
C. Feighery Ireland 8 68 0.5× 54 0.6× 21 0.3× 35 0.4× 15 0.2× 15 319
Lisa Brennan United States 8 295 2.0× 43 0.5× 88 1.0× 9 0.1× 73 0.9× 14 590
Paul J. Petruska United States 12 222 1.5× 55 0.6× 33 0.4× 11 0.1× 182 2.4× 28 609
Mary Taj United Kingdom 13 91 0.6× 38 0.4× 23 0.3× 35 0.4× 60 0.8× 29 550

Countries citing papers authored by Michael S. Milder

Since Specialization
Citations

This map shows the geographic impact of Michael S. Milder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Milder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Milder more than expected).

Fields of papers citing papers by Michael S. Milder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Milder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Milder. The network helps show where Michael S. Milder may publish in the future.

Co-authorship network of co-authors of Michael S. Milder

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Milder. A scholar is included among the top collaborators of Michael S. Milder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Milder. Michael S. Milder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bailey, Neil A., John M. Pagel, William Bensinger, et al.. (2018). A Single Center Retrospective Study of Real World Relapsed/Refractory DLBCL Patients Eligible for CAR T-Cell Therapy: Patient Characteristics and Outcomes. Blood. 132(Supplement 1). 1715–1715. 1 indexed citations
2.
Gribben, John G., Nancy L. Bartlett, Joe Stephenson, et al.. (2005). A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL). Biology of Blood and Marrow Transplantation. 11(2). 76–76. 1 indexed citations
3.
Gribben, JG, Joseph J. Stephenson, Nancy L. Bartlett, et al.. (2005). A phase II study of Xcellerated T Cells in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL). Journal of Clinical Oncology. 23(16_suppl). 2510–2510. 1 indexed citations
4.
Milder, Michael S., James D. Cook, Sunday M. Stray, & Clement A. Finch. (1980). Idiopathic Hemochromatosis, an Interim Report. Medicine. 59(1). 34–49. 165 indexed citations
5.
Milder, Michael S., James D. Cook, & Clement A. Finch. (1978). Influence of Food Iron Absorption on the Plasma Iron Level in Idiopathic Hemochromatosis. Acta Haematologica. 60(2). 65–75. 14 indexed citations
6.
Bonner, Hugh, et al.. (1974). Cavitating splenic infarction. The American Journal of Medicine. 56(5). 720–724. 5 indexed citations
7.
Arseneau, James C., et al.. (1974). The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies.. PubMed. 83(3). 489–95. 74 indexed citations
8.
Larson, Steven M., Michael S. Milder, & Gerald S. Johnston. (1973). Interpretation of the 67 Ga photoscan.. PubMed. 14(4). 208–14. 56 indexed citations
9.
Milder, Michael S., John H. Glick, Edward S. Henderson, & Gerald S. Johnston. (1973). 67GA scintigraphy in acute leukemia. Cancer. 32(4). 803–808. 22 indexed citations
10.
Milder, Michael S., et al.. (1973). False-positive liver scan due to breast prosthesis.. PubMed. 14(3). 189–189. 1 indexed citations
11.
Milder, Michael S., Steven M. Larson, Charles M. Bagley, et al.. (1973). Liver-spleen scan in hodgkin's disease. Cancer. 31(4). 826–834. 27 indexed citations
12.
Milder, Michael S., R. Frankel, Gregory B. Bulkley, Alfred S. Ketcham, & Gerald S. Johnston. (1973). Gallium-67 scintigraphy in malignant melanoma. Cancer. 32(6). 1350–1356. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026